myricanol has been researched along with Leukemia in 1 studies
*Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, KQ; Chen, X; Dai, GH; Fan, CJ; Li, ZH; Nie, XJ; Ren, ZM; Tong, YL | 1 |
1 other study(ies) available for myricanol and Leukemia
| Article | Year |
|---|---|
The mechanistic antitumor study of myricanol 5-fluorobenzyloxy ether in human leukemic cell HL-60.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 9; Cyclin-Dependent Kinase Inhibitor p21; Diarylheptanoids; Down-Regulation; Ether; Fas Ligand Protein; fas Receptor; G2 Phase Cell Cycle Checkpoints; HL-60 Cells; Humans; Leukemia; M Phase Cell Cycle Checkpoints; Proto-Oncogene Proteins c-bcl-2; Up-Regulation | 2017 |